Testosterone Is Not a Male Hormone: Levels, Dosing, and What It Does During Menopause
unPAUSED with Dr. Mary Claire Haver
Hosted by Dr. Mary Claire Haver
- 1h 12m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores the physiological role of testosterone in women, the history of its clinical regulation, and the common misconceptions surrounding its use during perimenopause and menopause. The host and the guest, urologist Dr. Mohit Kara, explain that testosterone is a crucial hormone for women—making up a larger volume than estradiol—yet remains without FDA-approved formulations due to historical underfunding in research. They examine how low testosterone presents in women, the complexities of blood testing including the role of sex hormone binding globulin, and how proper dosing and monitoring can safely improve symptoms like low libido, fatigue, and muscle loss.
The discussion also addresses the broader lifestyle framework needed for midlife health, touching on diet, exercise, sleep, stress reduction, and the impact of newer therapies like GLP-1s and peptides. Dr. Kara argues that testosterone therapy, when managed correctly with low starting doses, does not inherently cause severe side effects and can protect against conditions like sarcopenia and bone loss. Ultimately, the episode emphasizes that testosterone is a human hormone rather than a male one, and that women deserve evidence-based access and proper clinical evaluation to thrive in the second half of life.
- Women should check their hormone levels if they experience symptoms like low libido or fatigue because testosterone is essential for female health. 0:11
- Practitioners should always start patients on a low dose of testosterone and go slow to avoid side effects. 0:20
- Clinicians must look at total testosterone and consider free testosterone or SHBG levels, especially for women with ongoing symptoms. 22:13
- Patients taking testosterone should be properly monitored through regular blood tests at their trough levels every six months. 51:04
- Women over forty should insist on having their testosterone levels checked by their healthcare provider if they suspect a hormone deficiency. 1:06:34
Chapters
- 0:00Introduction and Funding Gap
The hosts introduce the episode, highlighting the lack of research funding for female testosterone and the historical bias favoring men.
- 4:23Personal Story of Female Sexual Dysfunction
Dr. Kara recounts a pivotal patient encounter that spurred his focus on treating women’s sexual health.
- 6:00Training Gaps in Sexual Dysfunction
Both hosts discuss how medical education rarely covers female sexual dysfunction, leading to inadequate care.
- 7:58Prevalence and Misconceptions of FSD
The conversation covers the high prevalence of female sexual dysfunction and common misconceptions about its causes.
- 10:26Testosterone Levels and Sources
The hosts explain where women produce testosterone, how levels change with menopause, and why they should be measured.
- 11:36Receptor Distribution and Benefits
They explore the widespread testosterone receptors in women and discuss potential benefits beyond libido.
- 13:22Funding and the TRAVERSE Trial
Dr. Kara details the massive TRAVERSE trial for men and contrasts it with the lack of similar studies for women.
- 30:56Historical Attempts to Approve Female Testosterone
They trace the history of attempts to bring testosterone to women’s market, including three major setbacks.
- 34:22Current Off-Label Use and Cost Issues
The hosts discuss how women currently use compounded testosterone, the high costs, and the regulatory challenges.
- 35:21Dosing Strategies and Monitoring
They cover practical dosing options—injectables, pellets, gels—and emphasize the importance of monitoring levels and side effects.
- 43:15Future Outlook and FDA Landscape
The episode concludes with optimism about upcoming FDA approvals and the need for clinician education on dosing and monitoring.
- 44:09Side Effects and Dose‑Response
The conversation explains how side effects are dose‑related, what to watch for, and how to manage them safely.
Highlights
- 4:40
Uncovering Low Female Libidostory
The guest shares how treating male sexual dysfunction led to patient complaints from partners, prompting him to learn about female sexual dysfunction and start treating both partners in 2007.
- 5:53
Lack of Medical School Trainingdata
Surveys reveal that half of medical students and sixty-five percent of residents receive zero training on sexual dysfunction, leaving clinicians unequipped to help patients.
- 7:59
High Prevalence of Untreated FSDdata
Female sexual dysfunction affects 48 percent of women, yet only 19 percent receive therapy due to a massive unmet need and physician discomfort.
- 10:56
Women Make More Testosteroneinsight
Women make about 300 micrograms of testosterone daily, and in terms of concentration, a woman makes more testosterone than estradiol.
- 13:22
The 500 Million Dollar Trialdata
The TRAVERSE trial cost over $500 million and involved 5,246 patients to prove that testosterone does not cause heart attacks in men, leading to the removal of the black box warning.
- 22:47
The Impact of Birth Control on SHBGinsight
Oral contraceptives can cause sex hormone binding globulin to remain permanently elevated, requiring higher testosterone dosing to overcome the binding.
- 39:28
Understanding Transdermal Absorptionstrategy
Topical gels and creams have varying penetrance rates among individuals, meaning higher milligram doses may be needed for partial absorbers to achieve the right blood level.
- 1:01:36
Sexual Dysfunction as a Couples Conditioninsight
Studies show that when a man develops erectile dysfunction, his partner has a 33 to 50 percent chance of developing female sexual dysfunction, proving that sexual health is a shared issue.
Quotes
“The funding for men is at least 20x or more than in women.”
Unnamed speaker · 0:13 “If you treat women for decades, you'll see it helps with muscle mass, depression, energy, mood, sleep.”
Unnamed speaker · 12:22 “The most common side effects are acne, facial hair, oily skin.”
Unnamed speaker · 44:25 “Women have a much higher content of testosterone than estradiol.”
Unnamed speaker · 15:03 “The higher her testosterone level, the increased bone mineral density she has.”
Unnamed speaker · 46:23 “If I give a man testosterone, can I decrease the risk of bone fracture? We're not there yet, right?”
Unnamed speaker · 47:05 “I would assume that if I'm going to increase her bone mineral density, I'm probably going to decrease the risk for fracture.”
Unnamed speaker · 47:15 “If you want the plane to go up, you want as much muscle mass as you got, as much bone mineral density.”
Unnamed speaker · 47:55 “Women make more testosterone than any other hormone in the body, including estrogen.”
Unnamed speaker · 1:11:38
About this episode
In this episode of unPAUSED, Dr. Mary Claire Haver sits down with Dr. Mohit Khera, board-certified urologist and Professor of Urology at Baylor College of Medicine, where he holds the F. Brantley Scott Chair in Urology, to tell women the truth about testosterone — the hormone women actually make more of than estrogen, yet still cannot access in a single FDA-approved formulation. Dr. Khera explains why testosterone is one of the most biologically active hormones in the female body, with receptors in the brain, heart, bone, muscle, and genitalia, and why the research to prove its full benefits for women has simply never been funded. He walks through what low testosterone really looks like, how to get tested properly, why women with low libido are so often handed an SSRI that makes things worse, the truth about pellets, creams, and injections, which side effects are reversible and which are not, and the red flags to watch for when looking for a prescriber. He also shares why sexual dysfunction is a couple's disease, what he calls the "hormonally dangerous decade," and the one intervention he's found that makes women feel even better than hormones. Guest links: Dr. Mohit Khera (Instagram) https://www.instagram.com/drmohitkhera/ Dr. Mohit Khera (X) https://twitter.com/DrMohitKhera Dr. Mohit Khera (LinkedIn) https://www.linkedin.com/in/drmohitkhera/ Dr. Mohit Khera (Website) https://drmohitkhera.com/ Dr. Mohit Khera at Baylor College of Medicine https://www.bcm.edu/people-search/mohit-khera-24469 Books: "The New Perimenopause," by Dr. Mary Claire Haver https://thepauselife.com/pages/the-new-perimenopause-book "The New Menopause," by Dr. Mary Claire Haver https://www.amazon.com/New-Menopause-Navigating-Through-Hormonal/dp/B0CKBZ4K1Z
Transcript
14,459 words · 2 speakers
Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.
Topics
- testosterone
- estrogen
- FDA
- sexual dysfunction
- SHBG
- progesterone
- depression
- bone mineral density
- breast cancer
- LCMS
Page updated · transcript and summary are machine-generated